ONCOTIME
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Mar 2026)
What this means for you
This application is over — abandoned 16 Mar 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98291104
- Mark type
- Design + words
- Filed
- 29 Nov 2023
- Published for opposition
- 18 Jun 2024
- Abandoned
- 16 Mar 2026
- Attorney of record
- Christopher D. Olszyk, Jr.
Goods and services
- Class 001 — Chemicals: Diagnostic reagents, other than for medical or veterinary purposes; diagnostic reagents for scientific or research use; reagents for scientific or medical research use
- Class 005 — Pharmaceuticals: Research use only chemical reagents for clinical medical or veterinary purposes; diagnostic reagents for medicinal research use
- Class 010 — Medical apparatus: Research use only biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for evaluating appropriate immunotherapy cancer treatments; Research use only cancer screening tests and devices, namely, medical devices for evaluating immunotherapy cancer treatment options; Research use only cancer screening tests and devices, namely, medical devices for matching cancer diagnosis with cancer treatments; Research use only medical diagnostic apparatus for testing a patient's response to various immunotherapy cancer treatment options in order to help determine the most effective course of treatment for that patient
- Class 042 — Scientific and technological services: Providing reagent sample testing and diagnostic services for others in the field of cancer testing research, tumor testing research, and screening for the purpose of evaluating patient immunotherapy cancer treatment options
Owner
- Oncocyte Corporation, Irvine, CA, US
- Oncocyte Corporation, Irvine, CA, US
Prosecution history
- 16 Mar 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Mar 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 14 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Aug 2025 — SOU EXTENSION 2 GRANTED
- 13 Aug 2025 — SOU EXTENSION 2 FILED
- 13 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Feb 2025 — SOU EXTENSION 1 GRANTED
- 13 Feb 2025 — SOU EXTENSION 1 FILED
- 12 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Jun 2024 — PUBLISHED FOR OPPOSITION
- 29 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 May 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER